Londy lands COO post at Accuray
This article was originally published in Clinica
Executive Summary
Accuray has promoted Kelly Londy to the role of chief operating officer. Londy was formerly chief commercial officer, a position she assumed when she joined the radiation oncology company in 2011. She has worked for two of the world’s largest medical imaging companies; Londy was vice-president and general manager of Molecular Imaging, at GE Healthcare North America before joining Accuray, and she has also held a similar position at Philips Healthcare North America. In her new role at Accuray, Londy will lead “all customer-facing activities, starting with product development and progressing through customer adoption and service, with a continued focus on customer satisfaction and consistent commercial execution."
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.